Clinical Trial Update: Roflumilast Versus Methotrexate in Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing roflumilast to methotrexate in psoriasis has completed Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Roflumilast (roflumilast)

Snippet

Sponsor: Cairo University | Conditions: Psoriasis | Phase 2, Phase 3 | Status: COMPLETED